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Supporting Information 
SI Materials and Methods 
General Surgical procedure. All surgical procedures were performed on male 
Lister-hooded rats which weighed 300-400 g at the start of the procedure. Each rat 
was anaesthetised with isoflurane (induction 4%, maintenance 2–3%) and secured in 
a stereotaxic frame with the incisor bar set at 3.3 mm below the interaural line. 
Injections of tracer or neurotoxin were made through burr holes at the co-ordinates 
outlined below. At the end of surgery each animal received fluid replacement therapy 
(5ml of saline containing 1 % glucose s.c.) and analgesia (0.05 ml Vetgesic i.m.). 
Hippocampal tracer injection. Anterograde tracer (200 nl dextran-conjugated 
AlexaFluor488 4% in phosphate-buffered saline (PBS), Life Technologies, Paisley, 
UK) was injected into the ventral hippocampus (-6.5mm from bregma, -4.5mm from 
midline,  6.4mm below dura at an angle of 10° to the vertical plane) by pressure 
injection using an UltraMicroPump 3 (World Precision Instruments) fitted with a 5 µl 
Hamilton syringe with a 33 gauge needle at a rate of 50 nl/min, with the needle left in 
situ for 10 min post-injection. Animals were anaesthetised with sodium pentobarbital 
7 days later and transcardially perfused with PBS followed by 4% paraformaldehyde 
and postfixed in paraformaldehyde for 24 h then transferred to 30 % sucrose in 0.2 
M phosphate buffer for 48 h before making coronal sections (40 µm) on a cryostat. 
Sections were mounted with Vectashield mounting medium (Vector Labs) containing 
1.5 µg/ml of DAPI. Images were obtained using a Leica DFC3000 FX camera 
mounted on a Leica DM5000B microscope with Leica GFP and A4 filter sets used to 
observe AlexaFluor488 and DAPI, respectively. 
Hippocampal lesions. Unilateral hippocampal excitotoxic lesions were made in six 
300-400g rats by making a series of injections of NMDA as indicated in Table 1. 
Modified coronal slices were cut, as detailed below, 21-28 days after the lesions and 
electrophysiological recordings were made from both hemispheres of PFC. The 
remaining tissue was fixed in paraformaldehyde for 48 h, transferred to 30 % 
sucrose in 0.2 M PBS for 48 h and sectioned at 40 µm on a cryostat before staining 
with cresyl violet.  To determine the extent of the lesions the remaining hippocampal 
tissue was measured in each hemisphere (Leica Qwin 3) in every fifth section 
between – 1.9 and -6.3 mm relative to bregma, and the remaining hippocampal 
tissue from the lesioned hemisphere expressed as a percentage of hippocampal 
tissue in the opposite hemisphere of the same sections. 
Slice preparation 
Animals were anaesthetised with isoflurane and decapitated. The brain was rapidly 
removed and placed in ice-cold (2-4°C) oxygenated (95 % O2-5 % CO2) artificial 
cerebrospinal fluid (aCSF) containing (mM): 124 NaCl, 3 KCl, 26 NaHCO3, 1.25 
NaH2PO4, 1 MgSO4, 10 D-glucose and 2 CaCl2. The brain was cut at an 11° 
modified coronal angle as described previously for the mouse (Parent et al 2009) 
using a custom brain matrix (Zivic Instruments, Pittsburgh, USA) and slices cut at 
400 µm using a vibratome before storing in room temperature aCSF for ≥ 1h before 
use. 
Electrophysiology 
Slices equivalent to +2.7 to +2.2 mm from bregma (Paxinos & Watson 1998) were 
transferred to a submerged recording chamber and perfused with aCSF at a rate of 2 
ml/min. For voltage-clamp experiments layer 5 neurons were patch clamped in the 
whole-cell configuration using borosilicate glass (GC150F-10, Harvard Apparatus, 
UK) electrodes 2-6 MΩ filled with a cesium methylsulfonate based solution (in mM: 
130 CsMeSO4, 8 NaCl, 10 HEPES, 0.5 EGTA, 4Mg-ATP, 0.3 Na-GTP, 5 QX-314-Cl, 
pH 7.25, 280-295 mOsm) at room temperature. Recordings were obtained using an 
Axon Multiclamp 700B amplifier (Molecular Devices) and WinLTP v1.11b (Anderson 
and Collingridge, 2007) or pClamp 10 (Molecular Devices) acquisition software, 
filtered at 4 kHz and digitised at 20 kHz (Digidata 1322A, Molecular Devices) without 
liquid junction potential correction. Cells where series resistance exceeded 30 MΩ or 
changed > 20 % were discarded. A concentric bipolar stimulating electrode 
(CBAPB50, FHC) was placed on the hippocampal fibre bundle and synaptic 
responses evoked using 0.1 ms constant-current pulses. Picrotoxin (50 µM) and 
NBQX (5 µM) were bath applied and cells were held at -40 mV to isolate EPSCNMDA. 
Activity dependent LTD was induced by delivery of 300 pulses at 5 Hz at baseline 
stimulus intensity. 
Current clamp recordings were performed at 31 ± 1°C using a potassium gluconate 
based intracellular solution (in mM: 145 K-gluconate, 5 NaCl, 10 HEPES, 0.5 EGTA, 
4 Mg-ATP, 0.3 Na-GTP, pH 7.25, 280-295 mOsm) and were acquired using 
pClamp10.2 software (Molecular Devices) low-pass filtered at 4 kHz and digitised at 
100 kHz. Cells were held at -70 mV by injecting constant current (liquid junction 
potentials corrected post-hoc) and single hippocampal-PFC EPSPs were evoked at 
0.1 Hz before delivering synaptic trains of 10 stimuli delivered at 20, 50 and 100 Hz. 
In some experiments NMDA receptors were blocked pharmacologically by bath 
applying 50 µM D-AP5 for 10 minutes before repeating synaptic measurements. In 
other experiments TFS was applied by switching to voltage-clamp and stimulating 
300 times at 5 Hz at Vholding = -40 mV. Single responses and trains were then re-
measured in current clamp during a 10 min period immediately following TFS, and 
again in a 10 min period 30 min after TFS. 
Analysis 
Data was analysed using WinLTP and Clampfit (Molecular Devices) and statistical 
analysis using SPSS 21 (IBM). Results are expressed as mean ± SEM unless 
indicated otherwise. Statistical analysis of current clamp data was performed using 
repeated measures ANOVA or paired t-test. Statistical analysis of plasticity 
experiments was assessed by averaging data points from the last 15 min of the 
experiment using one-way ANOVA with Bonferroni post-hoc comparisons to allow 
inclusion of a control data group to account for effects of rundown. EPSCNMDA decay 
time constants were fit by a double exponential function using Clampfit and a 
weighted time constant (τw) calculated  as τw = τfast*(Afast/(Afast + Aslow))+ 
τslow*(Aslow/(Aslow + Afast)) where A = amplitude. τw were compared using paired t-
tests. Statistical significance was set at 0.05 for all comparisons. Statistical analysis 
of the effects of hippocampal lesions on electrophysiology were performed using 










Figure S1. Recording of hippocampal-PFC synaptic transmission in the rat in 
vitro.  
Following labelling of the ventral hippocampal CA1 region with an anterograde tracer 
(A), fibres were observed running in a ventral-dorsal course (B, bottom right) and 
innervated infralimbic and prelimbic cortex (B, top right). Stimulation electrode is 
placed within hippocampal fibre bundle and recordings made from prelimbic layer 5. 
(C) To confirm the origin of the putative hippocampal fibre bundle, unilateral 
excitotoxic lesions were made in 6 animals. 21 days later volumetric lesion analysis 
showed 61 ± 8 % of hippocampal volume was lost. Largest (grey) and smallest 
(black) lesion volumes are shown. (D) In PFC slices contralateral to the lesion, 
stimulation of hippocampal afferents evoked large EPSCs in all cells (mean 
amplitude 299 ± 45 pA, n = 17 cells from 6 animals) whereas in slices from the 
ipsilateral hemisphere responses were absent or profoundly reduced in amplitude 
(38 ± 8.4 pA, n = 19 cells from 6 animals) when compared to the contralateral 
hemisphere (Mann-Whitney test, *** = p < 0.001). 
 
 
Figure S2. D2-like dopamine receptor activation does not regulate basal NMDA 
transmission nor expression of NMDA-LTD and induction of NMDA-LTD  does 
not require activation of NMDA receptors. (A) Bath application of sulpiride (10 
µM) had no effect on basal EPSCNMDA transmission (93.8 ± 4.5 % of baseline, n = 5, 
paired t-test t(4) = -1.127, p = 0.32). (B) The maintenance of LTD of EPSCNMDA (45.2 
± 8.2 % of baseline, n = 6) is unaffected by sulpiride (10 µM), when bath applied 30 
minutes later (44.7 ± 10.3 % of baseline, paired t-test t(5) = 0.192, p = 0.86).(C) 
Hyperpolarisation of cell to -100 mV during TFS (shaded region) prevented ionic 
conductance through NMDA receptors (dark grey trace, inset) but did not prevent 
induction of NMDAR-LTD (filled circles, 57.4 ± 5.5 % of baseline, n = 5, one-way 
ANOVA, Bonferroni post hoc vs TFS, p = 1.0). Hyperpolarisation to -100 mV in the 
absence of TFS was not sufficient to induce NMDAR-LTD (open cirlces, 87.1 ± 8.8 
%, n = 4, post hoc vs TFS p = 0.002, post hoc vs control p = 1.0). See Fig. 2E for 
summary. (D) Bath application of AP5 (50 µM, shaded region) before delivery of TFS 
did not prevent induction of LTD (filled circles, 56.4 ± 4.8 %, n = 8, Bonferroni post vs 
TBS alone p =1.0, Control p <0.001). Furthermore TFS applied in the presence of 
AP5 was significantly different to a control group AP5 applied in the absence of TFS 
(open circles, 74.6 ± 2.7 %, n = 8, Bonferroni post hoc, p = 0.041). The AP5 control 
group was not significantly different to time matched controls (p = 0.11). See Fig. 2E 
for summary. Insets show representative traces at baseline (black) and 46-60 mins 
(grey). 
 
Figure S3. (A) D1R-like dopamine receptor agonist SKF81297 (0.5 µM) had no 
effect on EPSCNMDA (98.9 ± 8.6 % of baseline, n = 5, one way-ANOVA, Bonferroni vs 
control p = 1.0, vs TFS p < 0.001). Bath application of muscarnic acetylcholine 
receptor antagonists (B) atropine (1 μM, 52.7 ± 4.6 %, n = 5; post hoc vs TFS alone 
p = 1.0) or (C) scopolamine (10 µM, 55.2 ± 9.4 % n = 6; post hoc vs TFS alone p = 
1.0) did not prevent induction of LTD by TFS. (D) Bath application of LY341495 at a 
concentration (100 µM) that acts as a broad spectrum mGluR antagonist did not 
prevent activity-dependent NMDAR-LTD (70.1 ± 4.6 %, n = 5, post hoc vs TFS alone 
p = 1.0). (E) LTD of EPSCNMDA by TFS (64.8 ± 2.1%, n = 5, light grey trace) was 
reversed by bath application of forskolin (10 µM, dark grey trace, 90.8 ± 10.8 % of 
baseline, paired t-test t(4) = -2.79, p = 0.495). (F) NMDAR-LTD induced by TFS was 
not blocked by bath application of GSK3β antagonists TDZD-8 (10 µM; 58.5 ± 7.1 %, 
n = 6; Bonferroni vs TFS: p = 1.0) or SB216763 (10 µM, 60.7 ± 5.6 %, n = 9, post 
hoc vs TFS alone p = 1.0). Insets show representative traces at baseline (black) and 
46-60 mins (grey). (A-D are summarised in Fig. 2F).  
 
Figure S4. Effects of NMDA receptor modulation on action potential firing. (A) 
Left: plot of action potentials fired during synaptic bursts at different frequencies 
before and after bath application of AP5 (50 μM), averaged across 3 cells. Right: 
example trace of a cell that fires in response to a 20 Hz synaptic burst before, but not 
after AP5. (B) Left: action potentials fired before and after TFS averaged across 4 
cells. Right: Example traces of cell spiking in response to a 50 Hz synaptic burst with 
spiking attenuated following TFS. (C) Left: A single cell fired in response to 50 and 
100 Hz synaptic bursts both before and after delivery of TFS in the presence of 
sulpiride. Right: example traces of 50 Hz bursts before and after TFS + sulpiride. 
Due to low experimental number statistical analyses were not performed on these 
data. 




